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Abstract. Over the last 200 years humans experienced a huge increase of life-
expectancy. These advances were largely driven by extrinsic improvements of
their environment (for example, the available diet, disease prevalence, vacci-
nation, and the state of hygiene and sanitation). In this paper we ask whether
future improvements of life-expectancy will be bounded from above by human
life-span. Life-span, in contrast to life-expectancy, is conceptualized as a bio-
logical measure of longevity driven by the intrinsic rate of bodily deterioration.
In order to pursue our question we ﬁrst present a modern theory of aging and
show that immutable life-span would put an upper limit on life-expectancy.
We then show for a sample of developed countries that human life-span thus
deﬁned was indeed constant until the 1950s but increased since then by about
eight years in sync with life-expectancy. In other words, we ﬁnd evidence for
manufactured life-span.
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For economists human-life span is a given constant. It is the upper bound “T” that we put
on top of the integral or sum sign when we compute expected life-time utility. Life-span diﬀers
conceptually from life-expectancy. Although we frequently treat life-expectancy, a measure,
which depends on the probability to survive from one period to the next, as a constant as well,
this is an assumption made “for convenience”, since survival depends certainly on the macro-
economic environment (GDP per capita, doctors per square kilometer etc) and on individual
economic decisions (nutrition, health expenditure etc).
While the majority of economic theory is based on the simplifying assumption that period
survival is certain or a given constant (based on Yaari, 1965, and Blanchard, 1985) there exists
also a by now rich literature that tries to endogenize survival and to incorporate empirically
plausible survival probabilities into economic reasoning. To the best of our knowledge, however,
there exists no research in economics on human life-span.1
With contrast to life-expectancy, which is population-speciﬁc and situation-speciﬁc, life-
span is usually conceptualized as a species-specic characteristic (Arking, 2006, Gavrilov and
Gavrilova, 1991). Life-expectancy of a population of mice, for example depends on the speciﬁc
environment in the wild or in the laboratory. Life-span of mice, in contrast, is independent
from such conditions but it diﬀers from the life-span of fruitﬂies or elephants. Likewise, life-
expectancy of a particular human population diﬀers across countries (England vs. Uganda) and
over time (England today vs. 200 years ago). Life-span of human beings, however, if it exists,
should be invariant across populations. Probably all biologists agree to this notion of life-span.
But how to measure life-span is – in contrast to life-expectancy – less easily agreed upon.
Deﬁning human life-span as the maximum attainable age at death, as suggested in many
general dictionaries and many older contributions in biology is certainly misleading (Wilmoth,
1999, Carey, 2003). Conceptually this idea is refuted by the insight that “however old we are,
our probability to die within the next hour is never equal to one” (Jacquard, 1982). Empirically
it has been refuted by the observation that maximum age at death has been continuously on
the rise for at least 140 years (Wilmoth and Robine, 2003).
1For economic theory with realistic survival probabilities see, for example, B¨ utler (2001), Boucekkine et al. (2002),
French (2005) Bloom, Canning, and Moore (2007), Bullard and Feigenbaum (2007), Hansen and Imrohoroglu
(2008), Heijdra and Romp (2008, 2009), and Kalemli-Ozcan and Weil (2010). A few economic papers, among
them Ben Porath (1967), Sunde and Cervellati (2005), and Hazan (2009), could be interpreted as studies on the
economic impact of increasing life-span, although they rarely call it so and ignore its biological foundation.
1The simple fact that the “sample size” of people who ever lived on earth is continuously rising
lets us expect that the maximum ever-observed life-length will rise as time proceeds. This is
impressively shown by Finch and Pike (1996). They deﬁne life-span T as the estimated age at
death of the last survivor of a population such that S(x) = 1/N is the probability to be the
last man standing out of N. Plugging 1/N into an empirically estimated Gompertzian survival
function they obtain a life-span of 105 years for N = 103 and 114 for N = 107. In general, the
dependence of maxima on sample size is a well-known fact of the statistics of extreme values
(Gumbel, 1958).
From these observations it should be clear that life-span, with contrast to life-expectancy,
cannot be deﬁned as a mere statistical measure without biological foundation. We need some
understanding about the biological mechanism of aging in order to infer an intrinsic mechanism
that governs the pace at which our bodies deteriorate. Following standard reasoning in modern
biology by taking aging and death as stochastic processes (Arking, 2006), we are interested in
whether a regularity exists which is common to all humans independently from environmental
and genetic characteristics. From this regularity, if it exists, we try to infer life-span not as an
absolute maximum but as the characteristic length of life.
We begin our pursuit of human life-span in Section 2 by introducing two very strong empirical
regularities, the Gompertz-Makeham law of mortality the compensation eﬀect of mortality. We
then introduce a modern theory of aging, and show how it explains these regularities and how it
leads to a reasonable conceptualization of human life-span. Quantitatively, thus deﬁned human
life-span can be inferred from the compensation eﬀect of mortality. In Section 3 we show how
an immutable human life-span would lead to a rectangularization of the survival curve and how
it would put an upper bound on future advances of human longevity.
We then re-examine the Gompertz-Makeham law and the compensation eﬀect over the long-
run and infer human life-span. We observe a time-invariant compensating eﬀect until the 1950s
for all countries in our sample. For the time after the 1950s we ﬁnd evidence for a secular increase
of human life-span. In other words we ﬁnd that human ingenuity has eﬀectively interfered with
nature and has created “manufactured life-time” (Carnes and Olshansky, 2007). Finally we
show that life-expectancy in the second half of the last century increased in sync with life-span.
To a large and increasing extent we are living longer because technological progress has changed
the way we age and the way our bodies decay.
22. Human Life-Span: Theory
2.1. The Gompertz Makeham Law of Mortality. All theories of human life-span are based
on a very strong empirical regularity, the Gompertz-Makeham law of mortality. It originates
from actuary Benjamin Gompertz (1825) who observed that there exists a long period of life,
ranging from about 30 to 90 years of age, for which age and mortality are log-linearly related.
Let µ(x) denote the force of mortality, that is the conditional probability to die at age x given
survival up to age x. The Gompertz law is then formally stated as µ(x) = Rexp(αx). Noting
that not all causes of death are age related, Makeham (1860) added a constant, which provides
the famous Gompertz-Makeham formula.
µ(x) = A + Rex. (1)
Taking both simplicity and precision into account, the Gompertz-Makeham formula is to
the present day the most appropriate, concise, and widely used formal description of aging
(Olshansky and Carnes, 1997). Its parameters are estimated with great precision with correlation
coeﬃcients above 0.9 not only for humans but also for species as diﬀerent as yeast, fruitﬂies,
and horses. The estimated coeﬃcients, of course, diﬀer greatly, reﬂecting the large variation in
life-span across species (Arking, 2006).
Using the Gompertz-Makeham law and solving ˙ S(x)/S(x) =  µ(x) we obtain the uncondi-









From S(x) we can infer life-expectancy (expected remaining years to live) at age x as L(x) =
∫ 1
x S(a)da/S(a).
Over the last century human life expectancy at birth increased by more than 20 years in
most of the fully developed countries (Riley, 2001). It is interesting to investigate how these
huge improvements of human longevity are captured by the Gompertz-Makeham law. For this
purpose it is helpful to isolate the Makeham-parameter A because it reﬂects age-unrelated forces
of mortality, i.e. background mortality (Bongaarts, 2005) or extrinsic mortality (Carnes and
Oshansky, 2007). We expect prevention, eradication, or cure of age-unrelated diseases to be
3reﬂected in changes of A. In contrast, any progress with respect to the aging process itself
would be reﬂected in a change of the age-dependent Gompertz-parameters R and α.
Over the last two centuries background mortality went down dramatically in the today fully
developed countries (for Sweden, for example, from 5.510 3 to 4.8˙ 10 4; Gavrilov and Gavrilova,
1991). With A being close to zero, future advances in life-expectancy will have to come from
improvements of age-dependent mortality. In other words, if technological progress could aﬀect
only background mortality but not the intrinsic rate of bodily decay, the observed trend of
improving life-expectancy at birth by about 3 month per year of birth (Oeppen and Vaupel,
2002) would not be sustainable in the future. Inspired by this fact some gerontologists have
concluded that future life-expectancy at birth will unlikely exceed 85 years (Fries, 1980, Carnes
and Olshansky, 2007). The problem with such a hypothesis is that – although the virtually
zero background mortality leaves no scope for improvement – we cannot (yet) see any slowdown
or convergence of life-expectancy in the data (Wilmoth, 1997, 1999). This means that recent
advances of life-expectancy must have originated from a change of the Gompertz parameters.
2.2. The Compensation Eﬀect of Mortality. The Gompertz-parameters α and R, which
are estimated with high precision for a given population, diﬀer actually across sexes, across
countries, and over time. This means that, while all humans seem to age according to a common
general law of mortality, the speciﬁc parameters governing this law depend on sex, provenance,
and year of birth. Furthermore, R and α seem to depend also on geography and tend to fall (in
the case of R) or rise (in the case of α) with economic development. Because of their instability
the Gompertz-parameters as such are thus not suitable to identify human-life span.
The Gompertz parameters, however, are not changing independently from each other but,
strikingly, in a speciﬁc way such that they preserve an inverse association between α and the
log of R. This fact is known as the Strehler-Mildvan correlation or the compensation eﬀect of
mortality (Strehler and Mildvan, 1960, Gavrilov and Gavrilova, 1991). It is exemplarily shown
for Sweden in Figure 1 and 2. Figure 1 shows the long-run trends for α and R. Over time,
the slope parameter α tends to rise and the level parameter R tends to fall. This means that
over time Swedish women tend to age at a faster speed but start out at lower initial mortality.
Below we show the generality of this phenomenon across countries and how it can be explained
by increasing initial redundancy in the reliability theory of aging.
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Left panel: Development of  over time. Right panel: Development of R over time.
Formally, the compensation eﬀect of mortality states that
logRit = logM   αit  T (3)
in which Rit and αit are the population- and year-speciﬁc parameters of the Gompertz law and
M and T are invariant parameters of the compensation eﬀect of mortality. Figure 2 shows the
correlation for Swedish females and males.
To see how the compensation eﬀect inspired a general theory of human aging insert (4) into
country- and sex-speciﬁc age-dependent mortality µx
i  µ(x)   A = Ri exp(αix) to obtain
µx = Me(x T). (4)
Observe that age-dependent mortality exhibits a ﬁxed point. Equation (4) predicts that all men
(and likewise all women) of a country’s population share a common force of mortality M at
age T independently from the year or century of birth. In other words, any improvement in
the initial force of mortality µ0 is compensated by a faster increase of µx with age. The ﬁnal
step in the derivation of human life-span is to conclude that T is approximately constant across
countries. This has been found by Gavrilov and Gavrilova (1991) for 209 human life-tables.
They thus interpret the focal point (T,M) as a species-specic constant. For humans the point
estimate was T = 95 years, identiﬁed by Gavrilov and Gavrilova as “the life-span of human
beings”.
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Correlation between log(R) and  for males (right) and females (left). Observations before 1950 are marked
blue, and observations after 1950 are marked red.
The diﬀerence between the Strehler-Mildvan correlation and the compensation eﬀect is that
Strehler and Mildvan (1960) in their original approach inferred the correlation from the Gom-
pertz law, without the Makeham amendment. In order to infer life-span properly, however,
the Gompertz parameter have to be derived from the Gompertz-Makeham law, with explicit
consideration of background mortality A. Otherwise, results would be biased and changes in
the extrinsic rate of mortality would be absorbed by the parameters governing the intrinsic rate
of mortality. This has been impressively demonstrated by Gavrilov and Gavrilova (1991) who
called the unbiased correlation the “compensation eﬀect of mortality”. Controlling for A is of
particular importance when background mortality is high, that is in the analysis of historical
data and of contemporaneous less developed countries.
2.3. Reliability Theory. The strong regularities identiﬁed by Gompertz law and the compen-
sation eﬀect suggest that all humans share a common mechanism of aging, a common stochastic
process according to which individual bodies lose function over time and bodily failures and
impairments are accumulated. The pursuit to rationalize these phenomena has inspired an ap-
plication of reliability theory (Barlow and Proschan, 1975) and produced the modern theory of
aging. Its main idea is based on redundancy within the human body which is depleted over
time. This notion of aging as accelerated loss of organ reserve is in line with the mainstream
view in the medical science. For example, initially, as a young adult, the functional capacity
of human organs is estimated to be tenfold higher than needed for survival. (Fries, 1980). It
accords also well with the modern view in biology, which conceptualizes aging and death as
6driven by accidental stochastic shocks on the molecular level (Arking, 2006). Here we sketch
a basic theory by Gavrilov and Gavrilova (1991, 2001) and refer to their work as well as to
Novoltsev (2006), Finkelstein (2008) and Milne (2008) for extensions.
A common characteristic of all reliability-based models is that organisms are conceptualized
as complex systems consisting of essential parts (e.g. organs, tissue) connected in series, which
are in turn built of smaller entities connected in parallel. Parallel connectivity means that every
reliability theory is built upon the idea of redundancy. Another common theme is a stochastic
failure rate for the basic entities. The notion of aging as driven by a “natural” stochastic process
helps to explain the “unfair” nature of human fate, i.e. why we actually observe large diﬀerences
of aging on the individual level. Reliability theory can explain why individuals raised under
equal conditions and/or built from the same genes (monozygotic twins) can age and eventually
die in very diﬀerent ways. At the same time the model provides a toehold to explain how
population- (e.g. country-) speciﬁc characteristics and the environment early in life have a
bearing on aggregate aging behavior of entire populations and/or sub-populations.
Suppose an organism consists of m irreplaceable blocks, i.e. blocks are connected in series
such that the organism dies if one block fails. Each block consists of n elements, connected in
parallel with age-independent failure rate λ. The probability for a block to expire before age
x is thus given by F(x) = [1   exp( λx)]
n. Suppose that many elements are initially defect.
The probability of an initially functioning element is given by q. It can then be shown that the
failure rate of the organism (i.e. the mortality rate) is approximately given by (5).







in which k  nq is the mean number of initially functioning elements and c is a constant to
provide a unitless result. The model thus explains Gompertz’ law. Taking log’s of R we get
logR = log(cmkλ)   k and inserting α = kλ we arrive at logR = logM   αT, with M  αmc
and T  1/λ. The model thus explains as well the compensation eﬀect of mortality.
For an interpretation of the result note that T is uniquely pinned down by λ, the age-
independent failure rate of an element. If λ is a species-speciﬁc constant, then the model
supports a unique focal point T, i.e. a species-speciﬁc life-span. Across species, T depends in-
versely on the robustness of its non-aging elements. Let’s reasonably assume that m, the number
7of irreplaceable blocks, is also a species-dependent constant. Then all variation within a species
results from variation of k = nq, the mean number of initially functioning elements. Suppose
that available nutrition (for mother and child) and disease exposure early in life have shaped k.
Taking the historic improvement in nutrition and health into account, the model then predicts
that with ongoing economic development people start out much better at young age but are
aging faster. Consequently, survival prospects and life-expectancy have improved at any age up
to age T.
In other words, a time-invariant compensation eﬀect of mortality would imply that better
health care and nutrition or, more generally, improvements of the economic environment through
technological progress have increased life-expectancy “only” through improving somatic redun-
dancy (for example, more healthy body cells; Fogel. 1994; Fogel and Costa, 1997). In order to
improve life-span T technological progress needs to have a bearing on λ, that is on the intrinsic
rate of bodily decay.
3. Implications of Time-Invariant Human Life-Span
3.1. Compression of Morbidity. The notion of a constant life-span T is sometimes expressed
as “rectangularization” or as “compression of morbidity” (Fries, 1980). These concepts are
illustrated in Figure 3. The left panel shows an improvement of the age-dependent force of
aging according to the Strehler-Mildvan correlation. The slope parameter α increases from 0.08
(blue line) to 0.11 (red line). This is about the actually observed average increase for women
during 20th century in our sample of countries. The level parameter R is assumed to adjusts in
a way that supports a ﬁxed point at T = 83.
The middle panel shows the implied unconditional survival rate S(x) and conveys the idea of
rectangularization. Compared to the beginning of the century a higher share of women reaches
an old age of, say 70 years, and expires then more quickly during their last years before death.
Visually, the survival curve becomes closer to rectangular over time. This implies that gains
in life-expectancy, for example brought forward by technological progress in medicine, decrease
with age as well, as demonstrated in the panel on the right hand side of Figure 3. Improvements
in health at earlier stages of life lead to a faster deterioration in old age, a compression of
morbidity, such that women reaching an age of T share the same force of mortality at the
beginning and at the end of the century.
8Figure 3. Aging under Compensation of Mortality


























































































A = 0:002,  = 0:08 (blue lines) and  = 0:11 (red lines), M = exp( 0:07), R = M exp(   T), T = 83.
For comparison, Figure 4 shows the eﬀect on survival and life-expectancy caused by an im-
proving level parameter R without compensation eﬀect. The slope parameter α is hold constant.
In this case the curves shift to the right at all ages, indicating that aging as such has been post-
poned at all ages and providing a visible increase of life-expectancy also for the old (see also
Vaupel, 2010). In terms of theory, the inherent failure rate of the elements of which humans are
constructed λ has been manipulated. Human life-span T increased.
Figure 4. Manufactured Life-Span

























































































A = 0:002,  = 0:011, R = 2:7  10
 5 (blue lines) and R = 0:9  10
 5 (red lines).
3.2. The Future of Longevity. In this section we show that if the compensation eﬀect of
mortality is time-invariant and M and T are species-speciﬁc constants, then future gains of
life-expectancy are bounded from above. This means that the notion of “broken limits to
life-expectancy” (Oeppen and Vaupel, 2002) inferred from extrapolation of past trends would
be ill-considered. Actually there would exist a certain limit to life-expectancy. In order to
9show this, we insert the compensation eﬀect of mortality, R = M exp( αT), into into (1).
Assuming that A is zero (which is reasonable approximation for contemporaneous fully developed
countries) we get the force of mortality µ = M exp[α(x   T)]. The implied survival at age x
is S(x) = exp(y)exp[ M/αexp(α(x   T))] with y  M/αexp( αT). For analytical simplicity




exp[ M/αexp(α(x   T))]dx. (6)













in which Γ is the incomplete gamma function. Applying the mean value theorem of integral















Thus, L(0) = 1/(αξ), implying, since y < ξ < 1 that L(0) < 1/(αy). This constraint turns
out to be very useful for the “curve discussion” of life expectancy. Taking the derivative of



















 ( αy) > 0 (8)
because L(0) < 1/(αy). That is, life-expectancy and life-span are positively correlated. Analo-
gously we obtain ∂L(0)/∂M < 0.
If the compensation eﬀect of mortality is time-invariant and M and T are constants, the only

































The sign of the derivative is ambiguous and there exists an extremum for α = α where ∂L/∂α =




1 + y + αyT
. (9)






1 + y + αyT

[
yαT(1 + αT)2   1
]
.
From this we conclude that the extremum is a maximum if






eT ) eMT  (1 + αT)2 < e1+T).
Since the slope of the exponential function is generally steeper than the slope of the quadratic,
we conclude that for suﬃciently large α there exists a maximum life expectancy. This in turn
means that life expectancy is eﬀectively bounded from above by life-span. Since y converges
very rapidly to zero with rising α, we expect maximum life-expectancy to be about T + 1/α.
Figure 5. Life-Expectancy is Bounded by Life-Span



















































Left panel: Life expectancy (blue solid line) and initial mortality log R under the compensation eﬀect of
mortality (3) (green dashed line) for alternative  and M = 0:26. The – almost indiscernible – maximum
life-span is assumed for  = 1:27. Right panel: life-expectancy for alternative values of  and M. Both panels:
lifespan T = 85.
Figure 5 visualizes these results for life-span T = 85. As the force of mortality α increases,
the logarithm of initial mortality logR declines according to the compensation eﬀect (3). This
is shown by the dashed green line in Figure 5, assuming that M = 0.26. Accordingly life-
expectancy at birth increases steeply for small α and reaches an almost indiscernible maximum
of 85.78 years at 1.27. Afterwards life-expectancy converges towards T from above (blue solid
line). The panel on the right hand side demonstrates robustness of this result by – hypothetically
– considering alternative survival rates M at age T. Life-expectancy is eﬀectively bounded by
life-span, implying that “broken limits to life-expectancy” are inconsistent with a time-invariant
11compensation eﬀect. In order to allow for “unlimited” life-expectancy, life-span of humans must
be modiﬁable.
4. Empirical Evidence
In this section we use the established methodology and investigate whether human life-span
is constant or modiﬁable. For that purpose we use data on 1  1 period death rates from the
Human Mortality Database. 1  1 means that the data come for single years of age in one
year time intervals. The Human Mortality Database contains detailed population and mortality
data for 37 countries (there are multiple data series for France, Germany, New Zealand and the
United Kingdom). The period of data coverage diﬀers from country to country. For Sweden, for
example, data is available way back to 1751, while for Chile data coverage starts only in 1992.
We conﬁne our analysis to countries that have full data coverage from 1900 through 1999 (12
countries) or 1950 through (26 countries). This way we ensure a consistent sample and that our
results are not due to changes in the sample composition.
Table 1. Slope Parameter α across Countries and Time
1900-24 1925-49 1950-74 1975-1999
Country male female male female male female male female
Australia 0.077 0.096 0.090 0.111
Austria 0.086 0.101 0.095 0.118
Belgium 0.086 0.090 0.089 0.093 0.088 0.101 0.089 0.116
Bulgaria 0.075 0.083 0.087 0.100
Canada 0.084 0.099 0.088 0.109
Czech Republic 0.085 0.099 0.084 0.106
Denmark 0.098 0.093 0.094 0.094 0.093 0.104 0.087 0.111
England & Wales 0.078 0.081 0.085 0.091 0.082 0.098 0.086 0.106
Finland 0.090 0.094 0.077 0.089 0.084 0.098 0.086 0.113
France 0.089 0.088 0.088 0.096 0.089 0.106 0.099 0.125
Germany 0.087 0.102 0.091 0.114
Hungary 0.091 0.098 0.084 0.103
Ireland 0.088 0.093 0.084 0.102
Italy 0.084 0.075 0.095 0.095 0.093 0.101 0.094 0.119
Japan 0.086 0.099 0.101 0.124
Netherlands 0.088 0.088 0.093 0.093 0.094 0.104 0.087 0.118
New Zealand 0.077 0.084 0.089 0.092 0.082 0.100 0.086 0.108
Northern Ireland 0.083 0.091 0.083 0.103
Norway 0.100 0.100 0.100 0.102 0.095 0.106 0.092 0.119
Portugal 0.088 0.098 0.092 0.111
Scotland 0.078 0.081 0.085 0.090 0.082 0.094 0.081 0.099
Slovakia 0.094 0.101 0.084 0.106
Spain 0.086 0.097 0.096 0.120
Sweden 0.101 0.100 0.099 0.099 0.096 0.104 0.098 0.120
Switzerland 0.084 0.082 0.086 0.090 0.092 0.105 0.100 0.127
United States 0.079 0.097 0.086 0.105
Average 0.088 0.088 0.090 0.094 0.087 0.099 0.090 0.112
124.1. The Gompertz Parameters. We begin with estimating the parameters of the Gompertz-
Makeham equation (1) by gender for all countries and years with the method of non-linear least
squares. It is well known from the literature that the Gompertz-Makeham equation does not
hold for young and very old people. We thus restrict the sample to ages 30 through 90. Both
Gompertz parameters are estimated with very high precision. The R2 is around 0.99 or higher in
all regressions. Figure A.1 in the appendix shows the distribution of the estimated parameters
divided by their respective standard errors. There is not a single case of an insigniﬁcant α
parameter. In the 1950-1999 sample, we lose one country-year observation due to an insigniﬁcant
estimate of the R parameter for Finland. In the 1900-1999 sample, we lose 18 country-year
observations due to insigniﬁcant estimates of the R parameter for Finland and New Zealand.
Table 2. Level Parameter log(R) across Countries and Time
1900-24 1925-49 1950-74 1975-1999
Country male female male female male female male female
Australia -8.24 -10.15 -9.58 -11.71
Austria -8.88 -10.34 -9.79 -12.06
Belgium -8.71 -9.16 -9.06 -9.53 -9.12 -10.41 -9.35 -11.99
Bulgaria -8.18 -8.90 -9.02 -10.27
Canada -9.00 -10.47 -9.44 -11.66
Czech Republic -8.71 -10.06 -8.68 -10.85
Denmark -9.89 -9.58 -9.62 -9.67 -9.67 -10.74 -9.21 -11.64
England & Wales -8.11 -8.54 -8.68 -9.47 -8.55 -10.27 -9.10 -11.19
Finland -9.04 -9.47 -8.06 -9.18 -8.62 -9.96 -9.07 -11.73
France -8.93 -9.03 -8.92 -9.73 -9.22 -10.95 -10.30 -12.97
Germany -8.98 -10.39 -9.50 -11.74
Hungary -9.23 -10.03 -8.72 -10.63
Ireland -9.07 -9.75 -8.87 -10.72
Italy -8.54 -7.85 -9.52 -9.59 -9.54 -10.44 -9.81 -12.28
Japan -8.82 -10.20 -10.50 -12.84
Netherlands -9.03 -9.08 -9.50 -9.60 -9.77 -10.73 -9.24 -12.30
New Zealand -8.29 -8.94 -9.20 -9.64 -8.67 -10.46 -9.21 -11.42
Northern Ireland -8.64 -9.59 -8.81 -10.83
Norway -10.21 -10.35 -10.27 -10.52 -9.88 -10.93 -9.71 -12.35
Portugal -9.03 -10.09 -9.62 -11.46
Scotland -8.14 -8.53 -8.65 -9.30 -8.50 -9.80 -8.56 -10.49
Slovakia -9.58 -10.33 -8.77 -10.89
Spain -9.01 -10.14 -10.11 -12.44
Sweden -10.22 -10.17 -10.03 -10.14 -9.88 -10.72 -10.19 -12.45
Switzerland -8.46 -8.42 -8.77 -9.26 -9.47 -10.71 -10.37 -13.08
United States -8.51 -10.34 -9.30 -11.29
Average -8.963 -9.095 -9.190 -9.635 -9.029 -10.265 -9.416 -11.665
The parameter estimates for α and log(R) are reported in Tables 1 and 2. For better visu-
alization we break the data down into 25-year periods and report period averages. The overall
trend shown in Section 2 for Sweden is clearly visible across all countries: α increases and R
13decreases over time. There are also interesting gender diﬀerences: α is higher for females than
for males, whereas R is higher for males than for females. On average, α increased for females
from 0.088 in 1900-24 to 0.112 in 1975-99. For males the increase is more modest, starting from
the same level in 1900-24 and reaching 0.090 in 1975-99. For females R decreased by more than
one order of magnitude from exp( 9.95) = 1.1  10 4 in 1900-24 to exp( 11.66) = 8.5  10 6
in 1975-99. Again, the decrease is somewhat more modest for males. Summarizing, across all
countries over the last century the trend shows that people become more healthy in young age
but are aging faster as they get older.2
4.2. Survival Probability. We next use the average parameters of the Gompertz equation to









Figure 6 shows the survival functions for average females and males in 1900-24 (solid lines) and
1975-99 (dashed lines). Two salient phenomena can be observed. First, a rectangularization or
compression of morbidity is clearly visible. In 1900-24 the decline of the survival probability
starts already around age 20 whereas in 1975-99 survival probability stays close to unity until
around age 40 and then declines more rapidly than in the ﬁrst quarter of the century. Second,
in addition to the rectangularization of the survival function, we observe also that the survival
function shifts to the right from period 1900-24 to 1975-99. The right shift is not uniform across
all ages, but clearly very old people are beneﬁtting from improved survival probabilities as well.
As explained in Section 2 this ﬁnding is inconsistent with a time-invariant compensation eﬀect
of mortality. It is a ﬁrst indication that human life span might be modiﬁable.
In Figure A.2 in the appendix we redo the analysis country by country. We take the period
averages of α and R for the ﬁrst available period and compare the obtained survival function
to the survival function in 1975-99 for each country. It turns out that the pattern that we have
2In a related study, Bongaarts (2005) estimates the parameters of the Gompertz law for 14 countries in the
period 1950-2000 and ﬁnds a “nearly constant” slope parameter ( in our notation) and a secularly falling level
parameter (R in our notation). It is tempting to conclude from Bongaarts’ ﬁnding of decreasing R that human
life-span has risen over the last half of the 20th century. On a closer look, however, this evidence is insuﬃcient for
a conclusion on human life span. Firstly,  and R are not species-speciﬁc parameters, they vary across countries
and sexes. Secondly, it is misleading to compare  and R at the same (absolute) scale. Inspection of (1) shows
that a unit change of  contributes as much to the force of mortality as a unit change of the logarithm of R.
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Dashed blue line: Survival function 1975-1999. Solid orange line: Survival function 1900-25.
illustrated for averages – rectangularization cum right shift of the survival function – is universal
across all countries.3
4.3. Human Life-Span. The observations from the previous section suggest that life span
T according to the deﬁnition from the compensation eﬀect of mortality is not constant but
changing over time. We substantiate this ﬁnding by estimating the compensation eﬀect. In the
model
log(Rit) = β0 + β1αit + ϵit. (11)
β1 represents the negative life span  T and β0 represents log(M), the mortality rate shared by
all humans of age T. Exploratory data analysis in Figure A.3 in the appendix suggests that the
slope coeﬃcient T indeed changes over time. Pooling the observations over a too long period
would lead to misleading results. We thus focus on the 26 countries, for which we have a full
data from 1950-1999, and estimate equation (11) with pooled OLS for 1950-74 and 1975-1999
respectively. The result is visualized in Figure 7. Red circles identify data points in the 1950-74
period and blue circles reﬂect the 1975-99 period. It is clearly visible that in the later period
an improvement of log(R) was associated with a somewhat smaller increase of α than in the
earlier period, implying that the slope – representing human life span – increased in absolute
value during the 20th century.
Table 3 reports the estimation results. During the second half of the 20th century female life
span increased from 89 years to about 96 years and male life span increased from 83.5 years
3Yashin et al. (2001) arrive at a similar conclusion using period and cohort data for a smaller sample of countries
(France, Japan, Sweden and the US).
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Data points 1975-99 (blue circles) and 1950-74 (red diamonds). The solid lines represent the pooled
OLS ﬁt for each period. The countries in the sample are: Australia, Austria, Belgium, Bulgaria,
Canada, Czech Republic, Denmark, England & Wales, Finland, France, Hungary, Iceland, Ireland,
Italy, Japan, Netherlands, New Zealand, Northern Ireland, Norway, Portugal, Scotland, Slovakia,
Spain, Sweden, Switzerland and United States.
to almost 96 years. These absolute number should be taken with some caution. Pooling the
data over (arbitrarily chosen) 25 year periods clearly has some unwanted side eﬀects if the slope
coeﬃcient changes over time. The main point that we want to make here is that the slope
coeﬃcient, that is human life span, was not time-invariant.4
Table 3. Human Life Span 1950-1999
1950-74 1975-1999
male female male female
T 83.5 88.9 95.7 96.7
(0.62) (0.77) (0.54) (0.64)
log(M) -1.78 -1.45 -0.85 -0.83
(0.05) (0.08) (0.05) (0.07)
R2 0.97 0.95 0.98 0.97
Standard errors in parentheses. The countries in the sample are: Australia, Austria, Belgium, Bulgaria,
Canada, Czech Republic, Denmark, England & Wales, Finland, France, Germany, Hungary, Ireland, Italy,
Japan, Netherlands, New Zealand, Northern Ireland, Norway, Portugal, Scotland, Slovakia, Spain, Sweden,
Switzerland and United States.
Expanding life-span, however is a fairly recent phenomenon. Extending the sample period
over the the whole last century provides supporting evidence for the notion of invariant life-span
4Recently, Zheng et al. (2011) arrived at a similar result. Their estimates, however were unfortunately based on
the Gompertz equation, without the Makeham amendment. Since their sample contained many less developed
countries, the bias incurred from ignoring background mortality was potentially large (see Gavrilov and Gavrilova,
1991). This potential bias may explain why they arrive at a much higher estimate of life-span (referred to as
the age of zero vitality according to the Strehler-Mildvan methodology) for a sample containing many developing
countries than we do for a sample of fully developed countries.
16during the ﬁrst half of the century. As shown in Table 4, we estimate with great precision a life-
span of about 88 years for both man and women in the 1900-1924 period as well as in the 1925-49
period. Then, in the 1950-74 period, female life-span took oﬀ and male life span followed in the
1975-99 period. Remarkably, male and female life-span are estimated to be about the same in
the earlier periods, as theory predicts. We interpret these results as follows. During the ﬁrst half
of the 20th century (and presumably also earlier in human history) the data supports the notion
of an invariant human life-span of about 88 years. Observable improvements of life-expectancy
during that period originated from declining background mortality (sanitation, vaccination)
and from a reduction of R in association of movement along the mortality compensation line,
indicating better (initial) physiological conditions (better nutrition, e.g. Fogel and Costa, 1997).
Then, in the later 20th century, “something” happened. According to reliability theory these
events eﬀectively manipulated the failure rate, that is the intrinsic rate of bodily decay.
Table 4. Human Life Span 1900-1999
1900-24 1925-49 1950-74 1975-99
male female male female male female male female
T 87.1 89.5 87.4 86.8 89.3 95.6 94.0 93.6
(0.75) (0.88) (0.87) (1.18) (0.83) (1.08) (0.48) (0.57)
log(M) -1.31 -1.22 -1.33 -1.50 -1.28 -0.77 -1.02 -1.22
(0.07) (0.08) (0.08) (0.11) (0.07) (0.11) (0.04) (0.07)
R2 0.98 0.97 0.97 0.95 0.97 0.96 0.99 0.99
Standard errors in parentheses. The countries in the sample are: Belgium, Den-
mark, England & Wales, Finland, France, Italy, Netherlands, New Zealand, Norway,
Scotland, Sweden and Switzerland.
4.4. Life Span and Life Expectancy. Finally we would like to explore the link between life-
span and life-expectancy empirically. For that purpose we estimate (11) annually from 1950 to
1999 for the sample of 26 countries for which we have consistent data and compare it with the
”frontier life expectancy” calculated by Oeppen and Vaupel (2002). We visualize the combined
data in Figure 8 in a simple scatter plot and add a spline ﬁt with a 95 percent conﬁdence interval
to it.
Interestingly, life span and frontier life expectancy are virtually uncorrelated during about
the ﬁrst 20 years of the observation period, which further corroborates the idea of improving
life-expectancy through lower background mortality or through better health and nutrition in
line with an invariant compensation eﬀect. Then, from about the 1970’s onwards we observe
17a strong positive correlation between the two variables, indicating that recent improvements in
life-expectancy were indeed driven at least partly by expanding human life-span.
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Life span for a given year is obtained by a simple linear cross-country regression of log(R) on .
The frontier life expectancy data is taken from Oeppen and Vaupel (2002). The solid line is a ﬁtted
spline with a 95 percent conﬁdence interval around it (shaded in gray). Countries as for Table 3.
The notion of an expanding human life-span is helpful to rationalize why other researchers
have not (yet) observed any convergence of increasing life-expectancy (Wilmoth, 1997, Vaupel,
2010). Predictions of a certain limit to life expectancy – for example, that it should not exceed
35 years at age of 50 (Olshansky et al, 1990) – are presumably made under the wrong perception
of an invariant human life-span, in which case they would have been indeed fully justiﬁed and
understandable as the analysis in Section 3.2 has shown. Unlike other species, however, humans
seem to be able to modify life-span such that there is no limit of life-expectancy visible in the
data.
5. Conclusions
In this paper we have introduced to the economics science a theoretical foundation of human
life-span based on two strong empirical regularities, the Gompertz-Makeham law and the com-
pensation eﬀect of mortality. We have estimated the parameters of the Gompertz-Makeham
model and found a remarkable long-run trend. Contemporaneous humans start out as young
adults much more healthy than their forefathers a century ago but they are also aging faster. For
a long time of our history this trend was consistent with the observation of rising life-expectancy
under an invariant life-span.
18If life-span were indeed immutable, as it is presumably for other animals, future improvements
in life-expectancy would soon end. Life expectancy, as we have shown in this paper, is bounded
from above by life-span. For the second half of the 20th century, however, we were able to
present evidence for expanding life-span. It increased quite signiﬁcantly by about 8 years. For
the last quarter of the 20th century we ﬁnd furthermore that life expectancy increased in sync
with life expectancy, a phenomenon that explains why other researchers have observed “broken
limits to life-expectancy” (Oeppen and Vaupel, 2002).
It is beyond the scope of the present paper to identify the cause of expanding life-span. Yet
theory suggests that the potential candidates have to be fairly recent events which manipulated
the failure rate of human body parts. The most natural candidates are probably regenerative
medicine and replacement surgery. To be more concrete, heart bypass operation and dialysis
machines are two prominent examples of medical innovations of the second half of the 20th
century which prolonged human lifes by replacing the functional performance of failed organs.
The notion of modiﬁable life-span is important for economists, policymakers as well as theo-
rists. Taking the “capital T” as constant may lead to severe misjudgements about the future of
population aging and the ﬁnancial stability, meaningfulness, and eﬃciency of social security and
public health systems. Also, on the individual level, the awareness of modiﬁable and potentially
further rising life-span beyond the “natural” improvements of life-expectancy, may have quite
dramatic eﬀects on life-cycle decisions like schooling, savings, and retirement. Re-considering our
conventional life-cycle theory and integrating the notion of expanding life-span is a challenging
task for future research.
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Dashed blue line: Survival function 1975-1999. Solid red line: Survival function 1950-74. Solid orange line:
Survival function 1900-24.
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Dashed blue line: Survival function 1975-1999. Solid red line: Survival function 1950-74. Solid orange line:
Survival function 1900-24.
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Dashed blue line: Survival function 1975-1999. Solid red line: Survival function 1950-74. Solid orange line:
Survival function 1900-24.
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Dashed blue line: Survival function 1975-1999. Solid red line: Survival function 1950-74. Solid orange line:
Survival function 1900-24.
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Dashed blue line: Survival function 1975-1999. Solid red line: Survival function 1950-74. Solid orange line:
Survival function 1900-24.
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Dashed blue line: Survival function 1975-1999. Solid red line: Survival function 1950-74. Solid orange line:
Survival function 1900-24.
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Dashed blue line: Survival function 1975-1999. Solid red line: Survival function 1950-74. Solid orange line:
Survival function 1900-24.






























































































































































































.07 .08 .09 .1
alpha
Bulgaria, Males
Data points 1975-99 (blue circles), 1950-74 (red diamonds), 1925-49 (green triangles) and 1900-24 (orange
rectangles). The solid lines represent the OLS ﬁt for each period.
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England & Wales, Males
Data points 1975-99 (blue circles), 1950-74 (red diamonds), 1925-49 (green triangles) and 1900-24 (orange
rectangles). The solid lines represent the OLS ﬁt for each period.
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Hungary, Males
Data points 1975-99 (blue circles), 1950-74 (red diamonds), 1925-49 (green triangles) and 1900-24 (orange
rectangles). The solid lines represent the OLS ﬁt for each period.
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Netherlands, Males
Data points 1975-99 (blue circles), 1950-74 (red diamonds), 1925-49 (green triangles) and 1900-24 (orange
rectangles). The solid lines represent the OLS ﬁt for each period.
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Portugal, Males
Data points 1975-99 (blue circles), 1950-74 (red diamonds), 1925-49 (green triangles) and 1900-24 (orange
rectangles). The solid lines represent the OLS ﬁt for each period.








































































































































































































.09 .095 .1 .105 .11
alpha
Sweden, Males
Data points 1975-99 (blue circles), 1950-74 (red diamonds), 1925-49 (green triangles) and 1900-24 (orange
rectangles). The solid lines represent the OLS ﬁt for each period.
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United States, Males
Data points 1975-99 (blue circles), 1950-74 (red diamonds), 1925-49 (green triangles) and 1900-24 (orange
rectangles). The solid lines represent the OLS ﬁt for each period.
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Data points 1975-99 (blue circles), 1950-74 (red diamonds), 1925-49 (green triangles) and 1900-24 (orange
rectangles). The solid lines represent the pooled OLS ﬁt for each period. The countries in the sample are:
Belgium, Denmark, England & Wales, Finland, France, Iceland, Italy, Netherlands, New Zealand, Norway,
Scotland, Sweden and Switzerland.
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